Volume : 13, Issue : 10, October – 2026
Title:
DESIGN AND IN VITRO EVALUATION OF FLUOXETINE ETHOSOMAL DRUG DELIVERY SYSTEM FOR BRAIN DELIVERY
Authors :
Bathini Santhoshi, Tallari Shiva prasad,Ully Sindhuja, Mela Sneha varsha, Pallapu Srivani, Maryam Sulthana
Abstract :
The present study was aimed at the formulation and evaluation of Fluoxetine-loaded ethosomes using varying concentrations of lipids to enhance drug delivery. Four formulations (F1–F4) were prepared and evaluated for physicochemical characteristics, drug-excipient compatibility, particle size, zeta potential, entrapment efficiency, in vitro drug release, and stability studies. Preformulation studies confirmed the purity and suitability of Fluoxetine for formulation development. FTIR studies demonstrated the compatibility between the drug and selected excipients without any significant interactions. The prepared ethosomes exhibited particle sizes ranging from 163 to 228 nm and zeta potential values between −21 and −32 mV, indicating good stability. SEM analysis confirmed the spherical morphology of the vesicles. Entrapment efficiency ranged from 65.80% to 84.50%, with formulation F4 showing the highest entrapment efficiency (84.50%). In vitro drug release studies revealed sustained release behavior, with F4 exhibiting the highest cumulative drug release of 94.2% over 8 hours. Accelerated stability studies conducted on the optimized formulation (F4) demonstrated satisfactory stability over a period of three months. Based on the overall findings, formulation F4 was identified as the optimized ethosomal formulation with desirable physicochemical properties, enhanced drug entrapment, sustained drug release, and good stability. Thus, Fluoxetine-loaded ethosomes may serve as a promising vesicular drug delivery system for improved therapeutic efficacy.
Keywords: Fluoxetine, Ethosomes, Vesicular drug delivery system, Entrapment efficiency, In vitro drug release, Stability studies.
Cite This Article:
Please cite this article in press Bathini Santhoshi et al., Design And In Vitro Evaluation Of Fluoxetine Ethosomal Drug Delivery System For Brain Delivery”.,. Indo Am. J. P. Sci, 2026; 13(10).
REFERENCES:
1. Drug Delivery Systems. Vyas SP, Khar RK. New Delhi: Vallabh Prakashan; 2012.
2. Touitou Elka, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. Journal of Controlled Release. 2000;65(3):403–418.
3. Elka Touitou. Ethosomes – innovative vesicular carriers for enhanced transdermal drug delivery. Colloids and Surfaces B: Biointerfaces. 2004;36(3–4):203–208.
4. Drug Delivery and Targeting: For Pharmacists and Pharmaceutical Scientists. Hillery AM, Lloyd AW, Swarbrick J. London: Taylor & Francis; 2001.
5. Targeted and Controlled Drug Delivery. Jain NK. New Delhi: CBS Publishers; 2008.
6. Vyas S. P., Khar R. K.. Controlled Drug Delivery: Concepts and Advances. New Delhi: Vallabh Prakashan; 2012.
7. Elka Touitou, Dayan N. Ethosomes for skin delivery. Journal of Controlled Release. 2001;65(3):403–418.
8. Novel Drug Delivery Systems. N. K. Jain. New Delhi: CBS Publishers; 2008.
9. Drug Delivery Systems. Vyas S. P., Khar R. K.. Vallabh Prakashan; 2012.
10. Pankaj Verma, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: An overview. Journal of Advanced Pharmaceutical Technology & Research. 2010;1(3):274–282.
11. Rakesh Kumar, et al. Ethosomes: A novel vesicular carrier for transdermal drug delivery. International Journal of Pharmaceutical Sciences Review and Research. 2011;7(1):47–52.
12. Transdermal Drug Delivery Systems. Tapash K. Ghosh, William R. Pfister, Yum SI. New York: Informa Healthcare; 2008.
13. Nanoparticulate Drug Delivery Systems. Deepak Thassu, Deleers M, Pathak Y. New York: Informa Healthcare; 2007.
14. Transdermal Drug Delivery Systems. Tapash K. Ghosh, William R. Pfister, Yum SI. New York: Informa Healthcare; 2008.
15. Sanjay K. Jain, Tiwary AK, Sapra B, Jain NK. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech. 2007;8(4):E111.
16. Gharat S, Momin M, Panchal U, Omri A. Novel ethosomal gel formulation for enhanced transdermal delivery of curcumin and cyclosporine: a preclinical approach to rheumatoid arthritis management. Drug Deliv. 2025 Dec;32(1):2512620.
17. Singh B, Day CM, Abdella S, Garg S. Alzheimer’s disease current therapies, novel drug delivery systems and future directions for better disease management. J Control Release. 2024 Mar;367:402-424.